---
title: "Elosulfase alfa - Mucopolysaccharidosis, mps-iv-a"
sidebar: mydoc_sidebar
permalink: db09051-mesh-d009085-1.html
toc: false 
---


Path ID: `DB09051_MESH_D009085_1`
{% include image.html url="images/db09051-mesh-d009085-1.png" file="db09051-mesh-d009085-1.png" alt="db09051-mesh-d009085-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C102295 | Elosulfase alfa | Drug |
| InterPro:IPR000479 | Mannose-6-phosphate receptor | GeneFamily |
| GO:0005764 | Lysosome | CellularComponent |
| MESH:D006025 | Glycosaminoglycan | ChemicalSubstance |
| MESH:D009085 | Mucopolysaccharidosis, MPS-IV-A | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Elosulfase Alfa | MOLECULARLY INTERACTS WITH | Mannose-6-Phosphate Receptor |
| Mannose-6-Phosphate Receptor | INCREASES UPTAKE OF | Lysosome |
| Lysosome | INCREASES DEGRADATION OF | Glycosaminoglycan |
| Glycosaminoglycan | MANIFESTATION OF | Mucopolysaccharidosis, Mps-Iv-A |
|---------|-----------|---------|

Comment: Elosulfase alfa is a synthetic version of N-acetylgalactosamine-6-sulfatase, used in enzyme replacement therapy

Reference: 
  - [https://go.drugbank.com/drugs/DB09051#mechanismofaction](https://go.drugbank.com/drugs/DB09051#mechanismofaction)
  - doi:10.2147/TACG.S69080
  - [https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125460s000lbl.pdf](https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125460s000lbl.pdf)
